Shire says ADHD patch works for adolescents Forbes AP , 10.30.09, 06:01 PM EDT NEW YORK -- Shire PLC says clinical studies show its attention deficit hyperactivity disorder patch Daytrana, which is approved ... Shire Reports Tolerability and Clinical Effects Results of Daytrana(R ... Reuters Market Report -- In Play (SHPGY) MSN Money Shire's ADHD treatment data to be presented at the Honolulu psychiatric meeting News-Medical.net RTT News - istockAnalyst.com (press release) all 44 news articles » |
Shire plc, the global specialty biopharmaceutical company, announced today that it will present key scientific data on its Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, INTUNIV- (guanfacine) Extended Release Tablets, Vyvanse- (lisdexamfetamine dimesylate) Capsules CII, and Daytrana- (methylphenidate transdermal system) CII, at a national meeting of psychiatrists to be held October ...
Shire plc, the global specialty biopharmaceutical company, announced today that it will present key scientific data on its Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, INTUNIV(TM) (guanfacine) Extended Release Tablets, Vyvanse®( ) (lisdexamfetamine dimesylate) Capsules CII, and Daytrana®( ) (methylphenidate transdermal system) CII, at a national meeting of psychiatrists to be held ...